Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

Published 2010 View Full Article

Authors

Keywords

Journal

INVESTIGATIONAL NEW DRUGS

Volume 29, Issue 6, Pages 1432-1440

Publisher

Springer Nature

Online

2010-03-24

DOI

10.1007/s10637-010-9420-8

References

View 5 related references

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

INVESTIGATIONAL NEW DRUGS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Become a Peeref-certified reviewer